[ad_1]
Serious side effect: AstraZeneca stops vaccine testing
| Reading time: 2 minutes
Corona vaccine testing stopped for the time being
The pharmaceutical company AstraZeneca stopped the clinical study of its corona vaccine as a precautionary measure after one of the participants developed health problems. The vaccine is in the third and final phase of the study.
The AstraZeneca vaccine is in the pivotal study phase with tens of thousands of participants and is considered great hope. But now the drug company has to stop testing. Apparently a test person is seriously ill.
reThe pharmaceutical company AstraZeneca stopped the clinical study of its corona vaccine as a precautionary measure after one of the participants developed health problems. The British company announced on Wednesday night that it was a routine measure for these cases. “In a large series of experiments, diseases occur randomly, but they must be examined by an independent party to verify this thoroughly.”
AstraZeneca will expedite the investigation so that the vaccine approval process is delayed as little as possible, he said. The ultimate goal of the review is to determine if the health problems were caused by the vaccine. During the arrest, no more study participants should be vaccinated and people who have been vaccinated should continue to be observed.
Unspecified health problems are an isolated case, the company stressed. The news website “STAT” first reported on the suspension of the study. A test person in the UK was ill, he said.
The New York Times reported, citing an informed person, that the health problem was transverse myelitis, an inflammation that hits the spinal cord and can be caused by viral infections. The active ingredient AZD1222 manufactured by AstraZeneca is based on the weakened version of a chimpanzee cold virus and is supposed to activate the immune system so that it can render Sars-CoV-2 harmless in the event of an infection.
The vaccine is currently in the third and final phase of the study with tens of thousands of participants and is considered one of the main candidates in the development of an effective vaccine against the new coronavirus.
Political pressure in the US
AstraZeneca and eight other pharmaceutical and biotech companies had only given guarantees Tuesday that they would not compromise safety by developing a corona vaccine. This unusual move came in light of concerns that there could be political pressure, especially in the US, to urgently approve the first vaccines before the November 3 presidential election.
The president of the United States, Donald Trump, promises almost daily that there will be a vaccine by the end of the year or possibly by the time of the elections.
